Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Propanc Biopharma, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Carlo Campiciano (Form 8-K filed 2026-07-14). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ionic Ventures, LLC (filed 2025-08-19).
Who is behind it
Propanc Biopharma, Inc.: incorporated in Delaware; business address in Camberwell, Victoria, C3; industry Pharmaceutical Preparations (S-1, 2026-10-05).
Officers and directors, each with the role and the filing that names them:
- James Nathanielsz: Executive Officer, Director (Form D, 2023-11-03)
- Julian Kenyon: Executive Officer, Director (Form D, 2023-11-03)
- Josef Zelinger: Director (Form D, 2023-11-03)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2025-11-14 | Ionic Ventures, LLC | 0% |
| Schedule 13G, 2025-08-19 | Ionic Ventures, LLC | 9.9% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-14 | Carlo Campiciano | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-11-03 | $40K | $40K |
| Form D, 2023-10-26 | $61K | $61K |
| Form D, 2023-08-31 | $55K | $55K |
| Form D, 2023-08-31 | $73K | $73K |
| Form D, 2023-08-30 | $120K | $120K |
| Form D, 2023-08-16 | $65K | $65K |
| Form D, 2023-08-15 | $45K | $45K |
Latest IPO step: Propanc Biopharma, Inc. filed to go public (S-1, 2026-10-05).
IPO filings: S-1, 2026-10-05, S-1, 2026-07-17, S-1, 2026-04-10, S-1/A, 2026-02-19, S-1, 2026-02-02.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/propanc-biopharma